Spoken Alpha
Can B Corp
Can B Corp manufactures and sells hemp-derived cannabinoid products including CBD tinctures, topicals, and capsules through its Pure Health Products division, operates hemp processing and R&D facilities, licenses durable medical devices for post-surgery recovery, and holds patents through its Nascent Pharma subsidiary covering liquid cannabis formulations for treating conditions including chronic pain, anxiety, and sleep disorders.
Can B Corp is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $857,058 market cap.
Behavioral analysis
Disclosures
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add NASC, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NASC.
$ curl https://api.spokenalpha.com/v1/companies/NASCFAQ
Spoken Alpha indexes NASC's earnings call transcripts at https://spokenalpha.com/companies/NASC. Each call links to attributed speakers and parsed analyst Q&A.
Can B Corp (NASC) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).